Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Emcure Pharmaceuticals Ltd

NSE: EMCURE · BSE: 544210 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹1,950.60
Market cap: ₹37,005 Cr
Revenue (annual): ₹9,204 Cr
Net profit (annual): ₹924.4 Cr
P/E (TTM): 36.6×Sector 50.4×
Promoter holding: 77.83%-0.04% QoQ
FII holding: 4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 2 Employee Stock Options 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Aug 2026 13:41 IST BSE

Financial Results

Emcure Pharmaceuticals Q1 FY27 Results: Net Profit ₹292.5 Cr, Up 36.2% YoY

Emcure Pharmaceuticals Ltd reported revenue from operations of ₹2,580 Cr (+22.8% YoY) and net profit of ₹292.5 Cr (+36.2% YoY) for Q1 FY27.

Key figure: Net profit ₹292.5 Cr · +36.2% YoY

Open full results → Read the filing ↗

5 May 2026 14:06 IST NSE

Financial Results

Emcure Pharmaceuticals Q4 FY26 Results: Net Profit ₹243.7 Cr, Up 23.6% YoY

Emcure Pharmaceuticals Ltd reported revenue from operations of ₹2,470 Cr (+16.7% YoY) and net profit of ₹243.7 Cr (+23.6% YoY) for Q4 FY26.

Key figure: Net profit ₹243.7 Cr · +23.6% YoY

Open full results → Read the filing ↗